{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:35:19Z","timestamp":1791394519488,"version":"4.3.3"},"reference-count":87,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T00:00:00Z","timestamp":1461024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"swedish research council (vr)"},{"DOI":"10.13039\/100008444","name":"Parkinsonfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008444","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Insamlingsstiftelsen vid Ume\u00e5 Universitet"},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"crossref"}]},{"name":"J.C. Kempes stiftelse"},{"name":"Hj\u00e4rnfonden (SE)"},{"DOI":"10.13039\/501100006285","name":"Magnus-Bergvalls stiftelse","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006285","id-type":"DOI","asserted-by":"crossref"}]},{"name":"O.E. och Edlas stiftelse"},{"DOI":"10.13039\/100007464","name":"Torsten S\u00f6derbergs stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007464","id-type":"DOI","asserted-by":"publisher"}]},{"name":"V\u00e4sterbottens L\u00e4ns lasting (ALF-medel)"},{"name":"Patientf\u00f6reningen FAMY\/AMYL"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0153529","type":"journal-article","created":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T18:16:12Z","timestamp":1461089772000},"page":"e0153529","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Tetrabromobisphenol A Is an Efficient Stabilizer of the Transthyretin Tetramer"],"prefix":"10.1371","volume":"11","author":[{"given":"Irina","family":"Iakovleva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshan","family":"Begum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristoffer","family":"Br\u00e4nnstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Wijsekera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik L.","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Elisabeth","family":"Sauer-Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Olofsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,4,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/jne.12271","article-title":"The diversity of mechanisms influenced by transthyretin in neurobiology: development, disease and endocrine disruption","volume":"27","author":"B Alshehri","year":"2015","journal-title":"J Neuroendocrinol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.2174\/092986712800269236","article-title":"Transthyretin deposition in familial amyloidotic polyneuropathy","volume":"19","author":"MJ Saraiva","year":"2012","journal-title":"Curr Med Chem"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.jacc.2015.09.075","article-title":"Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis","volume":"66","author":"MA Gertz","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40120-015-0031-3","article-title":"A Review of Tafamidis for the Treatment of Transthyretin-Related Amyloidosis","volume":"4","author":"M Waddington Cruz","year":"2015","journal-title":"Neurol Ther"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","article-title":"Transthyretin (TTR) cardiac amyloidosis","volume":"126","author":"FL Ruberg","year":"2012","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/joim.12383","article-title":"Cardiac amyloidosis: where are we today?","volume":"278","author":"KS Patel","year":"2015","journal-title":"J Intern Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1073\/pnas.87.7.2843","article-title":"Fibril in senile systemic amyloidosis is derived from normal transthyretin","volume":"87","author":"P Westermark","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/modpathol.2014.102","article-title":"Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis","volume":"28","author":"A Yanagisawa","year":"2015","journal-title":"Mod Pathol"},{"key":"ref9","article-title":"Understanding Pre-Eclampsia Using Alzheimer's Etiology: An Intriguing Viewpoint","author":"SB Cheng","year":"2015","journal-title":"Am J Reprod Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.ajpath.2013.07.022","article-title":"Transthyretin is dysregulated in preeclampsia, and its native form prevents the onset of disease in a preclinical mouse model","volume":"183","author":"SS Kalkunte","year":"2013","journal-title":"Am J Pathol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"9629","DOI":"10.1073\/pnas.1121005109","article-title":"Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade","volume":"109","author":"CE Bulawa","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"14943","DOI":"10.1073\/pnas.261419998","article-title":"The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis","volume":"98","author":"X Jiang","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","article-title":"Survival After Transplantation in Patients With Mutations Other Than Val30Met: Extracts From the FAP World Transplant Registry","author":"OB Suhr","year":"2015","journal-title":"Transplantation"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e0143456","DOI":"10.1371\/journal.pone.0143456","article-title":"Amyloid Cardiomyopathy in Hereditary Transthyretin V30M Amyloidosis\u2014Impact of Sex and Amyloid Fibril Composition","volume":"10","author":"S Arvidsson","year":"2015","journal-title":"PLOS One"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/lt.24058","article-title":"Liver transplantation in transthyretin amyloidosis: issues and challenges","volume":"21","author":"A Carvalho","year":"2015","journal-title":"Liver Transpl"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"15051","DOI":"10.1073\/pnas.93.26.15051","article-title":"Inhibiting transthyretin amyloid fibril formation via protein stabilization","volume":"93","author":"GJ Miroy","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","article-title":"Diagnosis and management of thyrotoxicosis","author":"B Vaidya","year":"2014","journal-title":"Diagnosis and management of thyrotoxicosis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/74082","article-title":"Rational design of potent human transthyretin amyloid disease inhibitors","volume":"7","author":"T Klabunde","year":"2000","journal-title":"Nat Struct Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/labinvest.3700059","article-title":"Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants","volume":"84","author":"SR Miller","year":"2004","journal-title":"Lab Invest"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.neures.2006.08.014","article-title":"Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis","volume":"56","author":"K Tojo","year":"2006","journal-title":"Neurosci Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e4124","DOI":"10.1371\/journal.pone.0004124","article-title":"Iodine atoms: a new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors","volume":"4","author":"T Mairal","year":"2009","journal-title":"PLOS One"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1016\/j.febslet.2011.06.030","article-title":"Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation","volume":"585","author":"N Ferreira","year":"2011","journal-title":"FEBS Lett"},{"issue":"Suppl 1","key":"ref23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/13506129.2012.668502","article-title":"Natural polyphenols as modulators of TTR amyloidogenesis: in vitro and in vivo evidences towards therapy","volume":"19","author":"N Ferreira","year":"2012","journal-title":"Amyloid"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbadis.2012.10.007","article-title":"Dietary curcumin counteracts extracellular transthyretin deposition: insights on the mechanism of amyloid inhibition","volume":"1832","author":"N Ferreira","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.3390\/ijms14035284","article-title":"Inhibition of Human Transthyretin Aggregation by Non-Steroidal Anti-Inflammatory Compounds: A Structural and Thermodynamic Analysis","volume":"14","author":"R Sant'anna","year":"2013","journal-title":"International Journal of Molecular Sciences"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"9110","DOI":"10.1021\/jm401061w","article-title":"Modulation of the fibrillogenesis inhibition properties of two transthyretin ligands by halogenation","volume":"56","author":"EY Cotrina","year":"2013","journal-title":"J Med Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1021\/co5001234","article-title":"Tuning transthyretin amyloidosis inhibition properties of iododiflunisal by combinatorial engineering of the nonsalicylic ring substitutions","volume":"17","author":"M Vilaro","year":"2015","journal-title":"ACS Comb Sci"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.3390\/ijms14035284","article-title":"Inhibition of human transthyretin aggregation by non-steroidal anti-inflammatory compounds: a structural and thermodynamic analysis","volume":"14","author":"RO Sant'anna","year":"2013","journal-title":"Int J Mol Sci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jsb.2012.07.008","article-title":"Flavonoid interactions with human transthyretin: combined structural and thermodynamic analysis","volume":"180","author":"DB Trivella","year":"2012","journal-title":"J Struct Biol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jsb.2010.10.003","article-title":"The binding of synthetic triiodo l-thyronine analogs to human transthyretin: molecular basis of cooperative and non-cooperative ligand recognition","volume":"173","author":"DB Trivella","year":"2011","journal-title":"J Struct Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"97ra81","DOI":"10.1126\/scitranslmed.3002473","article-title":"Potent kinetic stabilizers that prevent transthyretin-mediated cardiomyocyte proteotoxicity","volume":"3","author":"MM Alhamadsheh","year":"2011","journal-title":"Sci Transl Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"9992","DOI":"10.1073\/pnas.1300761110","article-title":"AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin","volume":"110","author":"SC Penchala","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.febslet.2015.02.020","article-title":"CHF5074 (CSP-1103) stabilizes human transthyretin in mice humanized at the transthyretin and retinol-binding protein loci","volume":"589","author":"Y Mu","year":"2015","journal-title":"FEBS Lett"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"6507","DOI":"10.1021\/acs.jmedchem.5b00544","article-title":"Enthalpic Forces Correlate with the Selectivity of Transthyretin-Stabilizing Ligands in Human Plasma","volume":"58","author":"I Iakovleva","year":"2015","journal-title":"J Med Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e48042","DOI":"10.1371\/journal.pone.0048042","article-title":"Serum and cerebrospinal fluid levels of transthyretin in Lewy body disorders with and without dementia","volume":"7","author":"W Maetzler","year":"2012","journal-title":"PLOS One"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/toxsci\/56.1.95","article-title":"Potent competitive interactions of some brominated flame retardants and related compounds with human transthyretin in vitro","volume":"56","author":"IA Meerts","year":"2000","journal-title":"Toxicol Sci"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/toxsci\/kfj187","article-title":"In vitro profiling of the endocrine-disrupting potency of brominated flame retardants","volume":"92","author":"T Hamers","year":"2006","journal-title":"Toxicol Sci"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1021\/ac051399i","article-title":"Biosensor recognition of thyroid-disrupting chemicals using transport proteins","volume":"78","author":"GR Marchesini","year":"2006","journal-title":"Anal Chem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.fct.2015.03.023","article-title":"Tetrabromobisphenol A (TBBPA): Possible modes of action of toxicity and carcinogenicity in rodents","volume":"80","author":"DY Lai","year":"2015","journal-title":"Food Chem Toxicol"},{"key":"ref40","unstructured":"Bromine Science and Environmental Forum (BSEF) BSEF poster on TBBPA."},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1001\/jama.2013.283815","article-title":"Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial","volume":"310","author":"JL Berk","year":"2013","journal-title":"JAMA"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1007\/s00415-013-7051-7","article-title":"Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy","volume":"260","author":"T Coelho","year":"2013","journal-title":"J Neurol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1212\/WNL.0b013e3182661eb1","article-title":"Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial","volume":"79","author":"T Coelho","year":"2012","journal-title":"Neurology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1021\/jm030347n","article-title":"Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis","volume":"47","author":"SL Adamski-Werner","year":"2004","journal-title":"J Med Chem"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.bbrc.2006.07.109","article-title":"Cell based screening of inhibitors of transthyretin aggregation","volume":"348","author":"N Reixach","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/13506120802524916","article-title":"Formation of cytotoxic transthyretin is not dependent on inter-molecular disulphide bridges commonly found within the amyloid form","volume":"15","author":"M Lindhagen-Persson","year":"2008","journal-title":"Amyloid"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1073\/pnas.0400062101","article-title":"Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture","volume":"101","author":"N Reixach","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0002-9440(10)63050-7","article-title":"Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates","volume":"159","author":"MM Sousa","year":"2001","journal-title":"Am J Pathol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/S0002-9440(10)64469-0","article-title":"Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro","volume":"161","author":"MM Sousa","year":"2002","journal-title":"Am J Pathol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/13506129.2015.1007497","article-title":"Oligomeric TTR V30M aggregates compromise cell viability, erythropoietin gene expression and promoter activity in the human hepatoma cell line Hep3B","volume":"22","author":"L Moreira","year":"2015","journal-title":"Amyloid"},{"key":"ref51","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20140155","article-title":"Amyloidogenic and non-amyloidogenic transthyretin variants interact differently with human cardiomyocytes: insights into early events of non-fibrillar tissue damage","volume":"35","author":"P Manral","year":"2015","journal-title":"Biosci Rep"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.bbrc.2008.10.121","article-title":"Prefibrillar transthyretin oligomers and cold stored native tetrameric transthyretin are cytotoxic in cell culture","volume":"377","author":"K Sorgjerd","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1021\/bi00635a031","article-title":"Analysis of thyroid hormone binding to human serum prealbumin by 8-anilinonaphthalene-1-sulfonate fluorescence","volume":"16","author":"SY Cheng","year":"1977","journal-title":"Biochemistry"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2174\/156800705774322076","article-title":"Small transthyretin (TTR) ligands as possible therapeutic agents in TTR amyloidoses","volume":"4","author":"MR Almeida","year":"2005","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1042\/BJ20042035","article-title":"Human transthyretin in complex with iododiflunisal: structural features associated with a potent amyloid inhibitor","volume":"388","author":"L Gales","year":"2005","journal-title":"Biochem J"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"e0128222","DOI":"10.1371\/journal.pone.0128222","article-title":"The flavonoid luteolin, but not luteolin-7-O-glucoside, prevents a transthyretin mediated toxic response","volume":"10","author":"I Iakovleva","year":"2015","journal-title":"PLOS One"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"53483","DOI":"10.1074\/jbc.M408053200","article-title":"The crystal structure of transthyretin in complex with diethylstilbestrol: a promising template for the design of amyloid inhibitors","volume":"279","author":"E Morais-de-Sa","year":"2004","journal-title":"J Biol Chem"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/cmdc.201300245","article-title":"Tafamidis (Vyndaqel): a light for FAP patients","volume":"8","author":"S Nencetti","year":"2013","journal-title":"ChemMedChem"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"e6290","DOI":"10.1371\/journal.pone.0006290","article-title":"Novel transthyretin amyloid fibril formation inhibitors: synthesis, biological evaluation, and X-ray structural analysis","volume":"4","author":"SK Palaninathan","year":"2009","journal-title":"PLOS One"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/abbi.2002.2779","article-title":"Inhibition of transthyretin amyloid fibril formation by 2,4-dinitrophenol through tetramer stabilization","volume":"400","author":"P Raghu","year":"2002","journal-title":"Arch Biochem Biophys"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"25997","DOI":"10.1074\/jbc.M101228200","article-title":"Synthesis of an analog of the thyroid hormone-binding protein transthyretin via regioselective chemical ligation","volume":"276","author":"JA Wilce","year":"2001","journal-title":"J Biol Chem"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.bbapap.2007.11.014","article-title":"Iodination of salicylic acid improves its binding to transthyretin","volume":"1784","author":"L Gales","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"8928","DOI":"10.1021\/jm500997m","article-title":"Inhibitory activities of propolis and its promising component, caffeic acid phenethyl ester, against amyloidogenesis of human transthyretin","volume":"57","author":"T Yokoyama","year":"2014","journal-title":"J Med Chem"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1016\/j.scitotenv.2009.08.037","article-title":"Brominated flame retardants in the Arctic environment\u2014trends and new candidates","volume":"408","author":"CA de Wit","year":"2010","journal-title":"Science of the Total Environment"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.envint.2013.11.017","article-title":"Polybrominated diphenyl ethers (PBDEs), hexabromocyclododecane (HBCD) and "novel" brominated flame retardants in house dust in Germany","volume":"64","author":"H Fromme","year":"2014","journal-title":"Environ Int"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"14291","DOI":"10.1021\/es503383h","article-title":"Degradation and metabolism of tetrabromobisphenol A (TBBPA) in submerged soil and soil-plant systems","volume":"48","author":"F Sun","year":"2014","journal-title":"Environ Sci Technol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/j.envpol.2010.02.010","article-title":"Biodegradation kinetics of selected brominated flame retardants in aerobic and anaerobic soil","volume":"158","author":"JR Nyholm","year":"2010","journal-title":"Environ Pollut"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.tox.2014.12.013","article-title":"A reproductive, developmental and neurobehavioral study following oral exposure of tetrabromobisphenol A on Sprague-Dawley rats","volume":"329","author":"RB Cope","year":"2015","journal-title":"Toxicology"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tox.2011.07.010","article-title":"Differences in neonatal neurotoxicity of brominated flame retardants, PBDE 99 and TBBPA, in mice","volume":"289","author":"H Viberg","year":"2011","journal-title":"Toxicology"},{"key":"ref70","unstructured":"National Toxicology Program (2014) Technical Report on the toxicology studies of tetrabromobisphenol A (CAS NO. 79\u201394\u20137) in F344\/NTac rats and B6C3F1\/N mice and toxicology and carcinogenesis study of tetrabromobisphenol A inWistar Han [Crl:WI(Han)] rats and B6C3F1\/N mice (gavage studies). NTP Technical Report 587."},{"key":"ref71","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/0192623314557335","article-title":"Environmental chemical exposure may contribute to uterine cancer development: studies with tetrabromobisphenol A","volume":"43","author":"JK Dunnick","year":"2015","journal-title":"Toxicol Pathol"},{"key":"ref72","unstructured":"European Medicines Agency (2011) Vyndaqel, Assessment report."},{"key":"ref73","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s002280000211","article-title":"Steady-state dispositions of valproate and diflunisal alone and coadministered to healthy volunteers","volume":"56","author":"RS Addison","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/13506120600960882","article-title":"Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis","volume":"13","author":"Y Sekijima","year":"2006","journal-title":"Amyloid"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/toxsci\/kfj132","article-title":"Toxicokinetics of tetrabromobisphenol a in humans and rats after oral administration","volume":"91","author":"UM Schauer","year":"2006","journal-title":"Toxicol Sci"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.toxrep.2014.03.005","article-title":"TITLE Disposition and kinetics of Tetrabromobisphenol A in female Wistar Han rats","volume":"1","author":"GA Knudsen","year":"2014","journal-title":"Toxicol Rep"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1080\/15287390903212907","article-title":"Nephrotoxic potential and toxicokinetics of tetrabromobisphenol A in rat for risk assessment","volume":"72","author":"MJ Kang","year":"2009","journal-title":"J Toxicol Environ Health A"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"8654","DOI":"10.1021\/bi00151a036","article-title":"Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro","volume":"31","author":"W Colon","year":"1992","journal-title":"Biochemistry"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejmech.2014.03.042","article-title":"Fluorinated benzophenone derivatives: balanced multipotent agents for Alzheimer's disease","volume":"78","author":"F Belluti","year":"2014","journal-title":"Eur J Med Chem"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1021\/jm801347s","article-title":"Toward optimization of the second aryl substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies","volume":"52","author":"SM Johnson","year":"2009","journal-title":"J Med Chem"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"Xds","volume":"66","author":"W Kabsch","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"MD Winn","year":"2011","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1006\/jmbi.2000.4078","article-title":"A comparative analysis of 23 structures of the amyloidogenic protein transthyretin","volume":"302","author":"A Hornberg","year":"2000","journal-title":"J Mol Biol"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"AJ McCoy","year":"2007","journal-title":"J Appl Crystallogr"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"PD Adams","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"P Emsley","year":"2004","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1107\/S0907444911007281","article-title":"Presenting your structures: the CCP4mg molecular-graphics software","volume":"67","author":"S McNicholas","year":"2011","journal-title":"Acta Crystallogr D Biol Crystallogr"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0153529","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T21:17:56Z","timestamp":1718486276000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0153529"}},"subtitle":[],"editor":[{"given":"David R","family":"Borchelt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,19]]},"references-count":87,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0153529","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,19]]}}}